Cover Image
市場調查報告書

心外科及心血管介入設備市場:各國 (美國、加拿大、印度、中國、日本、英國) 市場、企業簡介、佔有率、趨勢、分析、規模、機會、分類和2015年∼2021年的預測

Global Cardiology Surgical & Interventional Cardiology Devices Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 345630
出版日期 內容資訊 英文 143 Pages
商品交期: 請詢問到貨日
價格
Back to Top
心外科及心血管介入設備市場:各國 (美國、加拿大、印度、中國、日本、英國) 市場、企業簡介、佔有率、趨勢、分析、規模、機會、分類和2015年∼2021年的預測 Global Cardiology Surgical & Interventional Cardiology Devices Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日期: 2016年02月29日 內容資訊: 英文 143 Pages
簡介

全球心外科及心血管介入設備市場,美國為46%有最大的市場佔有率。歐洲在心血管手術設備中獲得27%的佔有率。一般認為以中國、日本等為首,亞太地區今後將最大幅成長。

本報告提供全球心外科及心血管介入設備市場相關調查、市場趨勢以及到2012年的收益預測與成長率、產業分析、競爭趨勢、各地區趨勢,及進入的主要企業簡介彙整。

第1章 目錄

第2章 市場概要

  • 市場預測方法
  • 價值鏈分析
  • 主要的購買標準
  • 主要策略
  • 夥伴關係、收購、合併
  • 產品上市

第3章 市場決策因素

  • 推動市場的要素
    • 文明病的增加
    • 醫療觀光
    • 醫療觀光組織
    • 全球醫療費急劇上升
    • 健康生活方式的認識提高
  • 阻礙市場的要素
    • 手術的高價
    • 影響市場成長的政府嚴苛政策
  • 市場機會
    • 醫療機器人的研究開發
    • 手術技術的進步
    • 美國FDA認證的醫療設備
  • 市場課題
    • 對醫院、診所來說的醫療設備引進的成本與課題
    • 可靠性的問題

第4章 市場分類

  • 心律管理
  • 手術
  • 影像設備
  • 導管

第5章 各地區市場分類

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 企業分析

  • Boston Scientific Corporation
  • C.R. Bard
  • Medtronic
  • Abbot Laboratories
  • St. Jude Medical
  • Cook Medical
  • Biosense Webster
  • Edwards Lifescience
  • 東芝 Medical Systems 株式會社
  • Lombard Medical
  • Atricure Inc
  • Atrium Medical Corporation
  • Hansen Medical
  • GE Healthcare
  • Philips Healthcare
  • Smith Medical
  • Berlin Heart
  • Cambridge Heart, Inc.
  • Johnson & Johnson

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HME-701114

The prevalence of heart diseases globally increases the demand for interventional cardiology surgeries. The cardiology surgeries are costly and have some risk factor attached - there is 3-5% probability of patient's death. The global increase in life style oriented diseases has indirectly put pressure on the economies of the nation. The patient alone does not bear the cost of the treatment. The funding comes from the government health programs, reimbursement policies and health insurances to enable the patient for getting treatment.

US is the largest market for the Cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from the China and Japan.

Key companies profiled include

  • 1. Abbott Cardiovascular
  • 2. Boston Scientific Corp.
  • 3. C.R. Bard, Inc.
  • 4. Cook Medical
  • 5. Medtronic. Inc
  • 6. Toshiba Medical systems
  • 7. Biosense Webster, Inc.
  • 8. Edwards Lifescience Corp.
  • 9. Lombard Medical,
  • 10. Atricure Inc.,
  • 11. Atrium Medical Corporation.,
  • 12. Johnson And Johnson,
  • 13. GE Healthcare (Interventional Imaging) ,
  • 14. Philips Healthcare(Interventional Imaging),
  • 15. Smiths Medical(Interventional Imaging),
  • 16. St. Judes Medical,
  • 17. Hansen Medical,
  • 18. Berlin Heart,
  • 19. Cambridge Heart

This Occams Research Report covers

  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. Deep profiles top competitive companies

Table of Contents

Chap 1.Executive summary

Chap 2.Market overview

  • 2.1.Market Estimation Methodology
  • 2.2.Value Chain analysis
    • 2.2.1.Suppliers
    • 2.2.2.Manufacturers
    • 2.2.3.Distributors & Retailers
    • 2.2.4.End Users
  • 2.3.Key Buying Criteria
    • 2.3.1.Quality
    • 2.3.2.Price
    • 2.3.3.Availability
    • 2.3.4.Success rate
  • 2.4.Key Strategies
    • 2.4.1.Innovation Is The Key Industry Strategy to Overcome Competition
  • 2.5.Partnerships, acquisitions and mergers
  • 2.6.Product Launch- a make or break marketing strategy

Chap 3.Market determinants

  • 3.1.Drivers
    • 3.1.1.Global increase in life style oriented diseases & fatalities
    • 3.1.2.Medical Tourism
    • 3.1.3.Medical Tourism Organizations
    • 3.1.4.Global increase in healthcare spending
    • 3.1.5.Increasing awareness of healthy lifestyle to drive the market
  • 3.2.Restraints
    • 3.2.1.High Cost of Surgeries
    • 3.2.2.Stringent government policies affect Cardiology market growth
  • 3.3.Opportunities
    • 3.3.1.Research and development to explore healthcare robotics
    • 3.3.2.Technological advancements in surgeries
    • 3.3.3.US FDA approved medical devices
  • 3.4.Challenges
    • 3.4.1.High cost and Adoption issues of medical devices for hospitals and clinics
    • 3.4.2.Reliability Issues

Chap 4.Market Segmentation

  • 4.1.Cardiac rhythm management
    • 4.1.1.Cardiac rhythm management devices
    • 4.1.2.ICD: Cardioverter/defibrillators (ICD's)
    • 4.1.3.Atrial Fibrillation
      • 4.1.3.1.Treatment Options for Atrial Fibrillation
      • 4.1.3.2.Cox-Maze Open Heart Procedure
      • 4.1.3.3.Catheter-based Cardiac Ablation Procedure
  • 4.2.Surgery
    • 4.2.1.Coronary arteries bypass grafting (CABG)
    • 4.2.2.Angioplasty
    • 4.2.3.Transmyocardial Laser Revascularization (TMR)
    • 4.2.4.Heart valve Repair/Replacement
    • 4.2.5.Arrhythmia Treatment
    • 4.2.6.Aneurysm Repair
    • 4.2.7.Heart Transplant
      • 4.2.7.1.Surgery to Place Ventricular Assist Devices or Total Artificial Hearts
    • 4.2.8.Open Heart Surgery
    • 4.2.9.Types of open heart surgery
    • 4.2.10.Off Pump Heart surgery
    • 4.2.11.Minimally invasive surgeries
  • 4.3.Imaging Devices
    • 4.3.1.Still Imaging
    • 4.3.2.Real time imaging
    • 4.3.3.Magnetic Resonance Angiogram (MRA)
    • 4.3.4.Fluoroscopy
    • 4.3.5.Echocardiography
  • 4.4.Cardiac Catheterization

Chap 5.Geographical Analysis

  • 5.1.North America
    • 5.1.1.United States (U.S.)
      • 5.1.1.1.US FDA is vigilant over interventional cardiology device market
    • 5.1.2.Canada
      • 5.1.2.1.CVD and other heart diseases are the leading cause of mortality in Canada
      • 5.1.2.2.Regulations in Canada
  • 5.2.Europe
    • 5.2.1.United Kingdom (UK)
    • 5.2.2.France
    • 5.2.3.Germany
    • 5.2.4.Italy
    • 5.2.5.Spain
  • 5.3.Asia Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.2.1.Diseases prevalent in China
    • 5.3.3.Japan
    • 5.3.4.Korea
    • 5.3.5.Taiwan
  • 5.4.Rest of the World
    • 5.4.1.Brazil
    • 5.4.2.Mexico
    • 5.4.3.South Africa

Chap 6.Corporate profile

  • 6.1.Boston Scientific Corporation
    • 6.1.1.Overview
    • 6.1.2.Boston Scientific Corporation products portfolio in Cardiac
    • 6.1.3.SCOT Analysis
  • 6.2.C.R. Bard
    • 6.2.1.Overview
    • 6.2.2.Bard product portfolio in Cardiac
    • 6.2.3.SCOT Analysis
  • 6.3.Medtronic
    • 6.3.1.Overview
    • 6.3.2.Medtronic product portfolio in Cardiac
    • 6.3.3.Strategic Moves
    • 6.3.4.SCOT Analysis
  • 6.4.Abbot Laboratories
    • 6.4.1.Overview
    • 6.4.2.Abbott laboratories portfolio in cardiac
    • 6.4.3.SCOT Analysis
  • 6.5.St. Jude Medical
    • 6.5.1.Overview
    • 6.5.2.St. Jude medical products portfolio in cardiac
    • 6.5.3.SCOT Analysis
  • 6.6.Cook Medical
    • 6.6.1.Overview
    • 6.6.2.Cook Medical products portfolio in cardiac:
    • 6.6.3.Strategic moves
    • 6.6.4.SCOT Analysis
  • 6.7.Biosense Webster
    • 6.7.1.Overview
    • 6.7.2.Biosense Webster products portfolio in cardiac
    • 6.7.3.SCOT Analysis
  • 6.8.Edwards Lifescience
    • 6.8.1.Overview
    • 6.8.2.Edwards Lifesciences products portfolio in cardiac
    • 6.8.3.Strategic moves
    • 6.8.4.SCOT Analysis
  • 6.9.Toshiba Medical Systems
    • 6.9.1.Overview
    • 6.9.2.Toshiba Medical System Products Portfolio in Cardiac
    • 6.9.3.SCOT Analysis
  • 6.10.Lombard Medical
    • 6.10.1.Overview
    • 6.10.2.Lombard Medical products portfolio in cardiac
    • 6.10.3.SCOT Analysis
  • 6.11.Atricure Inc
    • 6.11.1.Overview
    • 6.11.2.Atricure products portfolio in cardiac
    • 6.11.3.SCOT Analysis
  • 6.12.Atrium Medical Corporation
    • 6.12.1.Overview
    • 6.12.2.Atrium Medical products portfolio in cardiac
    • 6.12.3.SCOT Analysis
  • 6.13.Hansen Medical
    • 6.13.1.Overview
    • 6.13.2.Hansen medical Product Portfolio
    • 6.13.3.SCOT Analysis
  • 6.14.GE Healthcare
    • 6.14.1.Overview
    • 6.14.2.GE Healthcare Product Portfolio
    • 6.14.3.Strategic Moves
    • 6.14.4.SCOT Analysis
  • 6.15.Philips Healthcare
    • 6.15.1.Overview
    • 6.15.2.Phillips Healthcare Products Portfolio in Cardiac
    • 6.15.3.Strategic Moves (2013-14)
    • 6.15.4.SCOT Analysis
  • 6.16.Smith Medical
    • 6.16.1.Overview:134
    • 6.16.2.Smiths Medical Products Portfolio in Cardiac
    • 6.16.3.SCOT Analysis
  • 6.17.Berlin Heart
    • 6.17.1.Overview
    • 6.17.2.Berlin heart product portfolio in Cardiac
    • 6.17.3.Strategic Moves (2013-2014)
    • 6.17.4.SCOT Analysis
  • 6.18.Cambridge Heart, Inc.
    • 6.18.1.Overview
    • 6.18.2.Cambridge heart product portfolio in Cardiac
    • 6.18.3.SCOT Analysis
  • 6.19.Johnson & Johnson
    • 6.19.1.Overview
    • 6.19.2.SCOT Analysis
Back to Top